You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Therapy Areas: Infectious Diseases
Appili Therapeutics and Vitalex Biosciences secure NIAID contract for fungal vaccine development for up to USD40m
Login
Username:

Password:


Related Headlines

Sanofi appoints new global head of Research & Development Pharma

Lakewood-Amedex expands intellectual property portfolio with Australian Bisphosphocin patent

Replicate Bioscience awarded Gates Foundation grant to advance srRNA vaccine candidates for TB

Innoviva Specialty Therapeutics signs licensing agreement with Dr. Reddy's for XACDURO international expansion

Gilead Sciences mobilises remdesivir donation to support Ebola response in Uganda

RedHill Biopharma advancing opaganib options for Ebola outbreak

Transgene to present preclinical TG-MVA mpox vaccine data at World Congress on Infectious Diseases

Hyundai Bioscience says XAFTY available for Ebola and Hantavirus treatment

Apotex and Cumberland Pharmaceuticals to integrate their US branded businesses

Ondine Biomedical abstracts selected for 2026 World Congress on Infectious Diseases

26Health acquires Optimal Integrative Care

ECO Animal Health announces receipt of favourable USDA safety assessment for ECOVAXXIN MG poultry vaccine

Sino Biological launches 2026-2027 Northern Hemisphere influenza vaccine strain antigens

Novacyt completes acquisition of Southern Cross Diagnostics

Armata Pharmaceuticals' AP-SA02 receives QIDP designation from US FDA

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026